The 12 closest competitors and alternatives to Impact BioMedical, Inc. among biotech companies — ranked by similarity to what Impact BioMedical, Inc. actually does, not by market-cap band.
Subscribe to see Impact BioMedical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Impact BioMedical Inc. is a pioneering biotechnology company incorporated in 2018 and based in Houston, Texas, dedicated to discovering, developing, and patenting innovative healthcare products, drug pipelines, and technology platforms.
Impact BioMedical, Inc. is a biotech company headquartered in Houston, United States. It is publicly listed (IBO) with a market capitalisation of $37.9M. Xcout tracks 11 named people at Impact BioMedical, Inc., including Frank D. Heuszel (Chairman & Chief Executive Officer).
5 more named people on record for Impact BioMedical, Inc., with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to Impact BioMedical, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
EVOQ Medical, Inc. is a healthcare company engaged in drug pipelines, patents, clinical trials, and therapeutic technology platforms.
Biotechnology
Indi Molecular, Inc. is a biotechnology company focused on drug pipelines, therapeutic areas, patents, and clinical trials.
Life Sciences
ImStar Therapeutics Inc. is a biotechnology company headquartered in Vancouver, British Columbia, focused on breakthrough science and drug discovery.
Biotechnology
Minerva Biotechnologies Corp. is a biotechnology holding company based in Woburn, Massachusetts, engaged in drug pipelines and patent development.
Biotechnology
IpiNovyx Bio, Inc. is a biopharmaceutical company that discovers and develops targeted proteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Utilizing a proprietary technology platform, the company focuses on advancing selective and reversible immunoproteasome inhibitors to create safer and more effective therapies for patients.
Biotechnology
Irazú Bio partners with academic researchers and university centers to curate and advance translational research assets into IND-enabling studies and Phase 1 clinical trials. The company focuses on areas such as hypoxia tolerance, antiviral formulations, and adeno-associated virus gene therapy, subsequently licensing the developed assets to pharmaceutical companies or forming new ventures with venture capital groups.
Similar biotech company
HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.
Biotechnology
Adnexus Biotechnologies is a drug discovery and biotechnology company headquartered in Texas that focuses on delivering accessible and affordable therapeutic solutions.
Biotechnology
Integrated Biosciences is a physical AI and biotechnology research company developing multimodal biological approaches to engineer the future of aging.
Biotechnology
CHARM Therapeutics Inc. is a biopharmaceutical company utilizing proprietary technology platforms for drug discovery and therapeutic pipeline development.
Biotechnology
HeartBeat.bio is a biotechnology company founded in 2021 and located at the Vienna BioCenter in Austria, specializing in cardiac drug discovery. The company transforms cardiac drug recovery and development using innovative technologies originating from the Institute of Molecular Biotechnology (IMBA).
Similar biotech company
Inventisbio is a biopharmaceutical company that focuses on the discovery and development of innovative drugs for major diseases such as tumors, autoimmune diseases, and metabolic disorders. Utilizing an independent research and development platform, the company creates proprietary drug pipelines targeting oncology drivers, kinases, and autoimmune pathways to serve patients globally.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Impact BioMedical, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →